Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders' Deficit

v3.20.2
Statements of Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2018 $ 928 $ 2,046,056 $ (2,548,735) $ (501,751)
Balance, shares at Mar. 31, 2018 9,275,000      
Stock-based compensation expense 1,014,690 1,014,690
Issuance of common stock in connection with notes payable $ 60 239,940 240,000
Issuance of common stock in connection with notes payable, shares 600,000      
Beneficial conversion feature in connection with notes payable 148,171 148,171
Net loss (4,295,753) (4,295,753)
Balance at Mar. 31, 2019 $ 988 3,448,857 (6,844,488) (3,394,643)
Balance, shares at Mar. 31, 2019 9,875,000      
Issuance of common stock in connection with a consulting agreement   354,953 355,000
Issuance of common stock in connection with a consulting agreement, shares 473,333      
Stock-based compensation expense $ 600 4,495,569 4,496,169
Stock-based compensation expense, shares 6,000,000      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 10 264,510 264,520
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 100,000      
Issuance of common stock in connection with notes payable $ 88 662,162 662,250
Issuance of common stock in connection with notes payable, shares 876,000      
Beneficial conversion feature in connection with notes payable 260,078 260,078
Net loss (9,603,871) (9,603,871)
Balance at Mar. 31, 2020 $ 1,733 $ 9,486,129 $ (16,448,359) $ (6,960,497)
Balance, shares at Mar. 31, 2020 17,324,333